AlloVir, Baylor ally to develop COVID-19 T-cell therapy

AlloVir, Baylor ally to develop COVID-19 T-cell therapy

Source: 
Fierce Biotech
snippet: 

AlloVir and Baylor College of Medicine have teamed up to develop T-cell therapies against the novel coronavirus behind the COVID-19 pandemic outbreak. The alliance builds on existing work to create off-the-shelf cell therapies that identify and eliminate specific viruses.